Introduction
Human lactoferrin (Lf), a 80-kDa glycoprotein, is a unique multifunctional protein, which modulates cell growth and a variety of cellular and immune responses (Galbraith, 1986) . It regulates granulopoiesis by inhibiting myelopoiesis via inhibition of macrophage and monocyte colony-stimulating factor production (Bagby, 1989) . Lf also regulates cytokine production and influences the activity of natural killer and other cells, enhancing their cytotoxic effects in cancers (Shau et al., 1992) . Recently, Lf was reported to function as a transcription factor (He and Furmanski, 1995) : it was suggested that Lf enters the nucleus and activates gene transcription by binding to specific DNA sequences. However, mechanisms underlying this action of Lf have not established, and little is known about the target genes.
Nuclear factor-kB (NF-kB) is a heterodimeric transcription factor composed in mammals of five family members including p50/NF-kB1, NF-kB2, p65/RelA, RelB, and c-Rel. It plays a critical role in inflammation and immune responses (Li and Verma, 2002) . In most cell types, NF-kB is retained in an inactive form in the cytoplasm by binding to a member of the IkB family. Various stimuli such as stresses, viruses, and proinflammatory cytokines (e.g. interleukin (IL)-1 and tumor necrosis factor (TNF)) trigger signaling cascades leading to IkB-kinase (IKK) activation and the consequent phosphorylation of IkB, which results in the release and nuclear translocation of NF-kB (Li and Verma, 2002) . Among the NF-kB activation pathways, those involving TNF-a and IL-1 are well understood (Baud and Karin, 2001; Li and Verma, 2002) . In both these pathways, ligand binding to the receptors, members of the TNFR superfamily and Toll/IL-1R family, recruits several TNF receptor-associated factors (TRAFs) (TRAF1, TRAF2, TRAF5, and TRAF6), thereby activating NF-kB. TRAF2 and TRAF6 interact directly with NIK and MEKK1 and activate the respective kinases, which transduce the signal to IKKs Baud et al., 1999) . Also, NIK and MEKK1 have been shown to phosphorylate IKKs in vivo and in vitro (Lee et al., 1998; Ling et al., 1998) . However, more research is required to elucidate the signaling pathways activated by TNF or IL-1. p53, the most commonly mutated gene in human cancers, is a tumor suppressor protein that induces apoptotic cell death. In response to various stresses, p53 is activated by phosphorylation via signaling cascades. Active p53 specifically functions as a transactivator of target genes, p21 waf1/cip1 , gadd45, fas/apo1, bax, mdm2, and others that are closely involved in growth arrest, apoptosis, and repair of altered DNA (El-Deiry, 1998) . Among the transcriptional targets for p53 is the Mdm2 oncoprotein, which regulates p53 levels by targeting p53 degradation in an autoregulatory feedback loop (Haupt et al., 1997) . Also, wild-type p53 is known to regulate transcription of p21 waf1/cip1 that binds the cyclinE-Cdk2 complex. Therefore, we have examined whether the promoter region containing the NF-kB binding element on p53 gene is consequently indispensable for Lfinduced transactivation of these p53 target genes.
In a previous report, we demonstrated that transiently expressed Lf strongly activated the expression of the matrix metalloproteinase 1 gene via AP-1 activation, without direct binding of Lf to its promoter (Oh et al., 2001) . We also showed that both the c-Jun NH 2 -terminal kinase (JNK) and p38MAPK (mitogen-activated protein kinases) signaling pathways are closely involved in Lf-mediated AP-1 activation. Here, we demonstrate that either transient or stable expression of Lf greatly induces NF-kB activation signaling cascade and consequently upregulates p53 and its target genes. To clarify the signaling pathways underlying this Lf-induced NF-kB activation, we employed dominantnegative mutants and inhibitors of several kinases, which are pivotal effectors in NF-kB activation pathways. We reveal that the signal transduction cascade through NIK or MEKK1, IKKa, and IKKb plays a key role in Lf induction of NF-kB activity, thereby stimulating expression of NF-kB target genes.
Results

Lf upregulates p53-responsive genes as well as p53 at the transcription level
During the investigation of Lf-responsive genes, we have found that Lf led to the induction of endogenous p53 gene (Figure 1 ). The protein level as well as mRNA level of p53 gene was greatly increased in HeLa-Lf cells. We next examined whether this Lf induction of p53 indeed affected the expression of p53-responsive genes, p21 waf1/cip1 and mdm2. As shown in Figure 1a , mRNA levels of both p21 waf1/cip1 and mdm2 genes, normalized to GAPDH levels, were markedly augmented in HeLa-Lf cells, indicating that Lf induces p53 activation and consequently alters the expression of p53-responsive genes. Next, RNAi experiment was performed to examine waf1/cip1 , and mdm2 mRNA in HeLa-pCI-neo (À) and HeLaLf ( þ ) cells were determined by RT-PCR. GAPDH served as an internal control. The fold increase in mRNA level relative to that of GAPDH is indicated. (b) HeLa-pCI-neo (À) and HeLa-Lf ( þ ) cells were transfected with RNAiFect (Qiagen) containing 21-mer siRNA oligonucleotides duplex directed against either Lf or GFP (Qiagen). At 72 h post-transfection, total RNAs were prepared from each cell. RT-PCR was performed as described in 'Materials and methods'. GAPDH served as an internal control. (c) Cellular lysates were prepared from HeLa-pCI-neo (À) or HeLa-Lf ( þ ) cells, subjected to SDS-PAGE, and electrotransferred to an Immobilon-P membrane (Millipore). The blot was probed with anti-p53 antibody. The membrane was stripped and reprobed with anti-actin antibody, which was used as loading control. (d) HeLapCI-neo (H-neo) or HeLa-Lf (H-Lf) cells were transiently transfected with a luciferase reporter plasmid (5 mg) driven by p21 promoter (WWP-Luc) or mdm2 promoter (mdm2-Luc). Following transfection, cells were immediately incubated with 20 mM pifithrina (PFT-a) or its vehicle Me 2 SO (DMSO). Error bars represent the s.e. over three independent experiments carried out in duplicate. (e) HeLa-pCI-neo (H-neo) or HeLa-Lf (H-Lf) cells were transfected with each 5 mg of WWP-Luc or mdm2-Luc plus Mdm2 expression vector (mdm2) or empty vector. After transfection, 2.5 mg/ml mitomycin C (MMC) was treated for 24 h. Data are the mean7s.e. for three independent experiments in duplicate whether the induction of p53 indeed resulted from the expression of Lf. In HeLa-Lf cells, while mRNA level of p53 gene was markedly increased, transfection of Lf siRNA into HeLa-Lf cells efficiently abrogated the Lfinduced p53 activation (Figure 1b ). This result strongly indicates that the upregulation of p53 gene is truly due to the expression of Lf. We also determined the effect of Lf on the transcriptional activity of p53-dependent genes in the presence or absence of the p53 inhibitor, pifithrin-a, or mitomycin C as a means of inducing DNA damage. HeLa-Lf cells showed greatly enhanced transcription of luciferase reporter genes driven by both the mdm2 and p21 waf1/cip1 promoters. These transcriptional activities were diminished by treatment of the cells with pifithrin-a ( Figure 1d ) and stimulated by treatment with mitomycin C (Figure 1d ). Moreover, overexpression of wild-type Mdm2 markedly reduced the induction of mdm2 and p21 waf1/cip1 by Lf, indicating that Mdm2 may be closely involved in Lf-mediated p53 activation. These results suggest that the Lf-induced upregulation occurs at the level of transcription of the respective genes by a transactivation process.
Lf
Lf transactivates the human p53 gene promoter via NF-kB
Having established that p53 is activated in HeLa-Lf cells, we investigated the activation mechanism. Overexpressed Lf strongly transactivated the p53 promoter linked to the reporter gene CAT via NF-kB (Figure 2 ). Transcription of CAT containing the 5 0 -flanking and promoter fragments of p53 from positions À325 to þ 12 was stimulated at least 20-fold. Since the extent to which a putative AP-1 site contributes to p53 transcription is somewhat controversial (Ginsberg et al., 1990; Kirch et al., 1999) , we designed the p53 promoter construct not to contain the region spanning the putative AP-1 site. The p53 promoter was further analysed to identify an Lf-responsive element. Nested deletion of the promoter up to the À80/ þ 12 region slightly reduced the Lfresponsive transactivation, but a moderately high inducibility of the chimeric gene by Lf was still preserved (Figure 2a) . However, further deletion to À50/ þ 12 almost completely abolished activation by Lf, suggesting that the most important Lf-responsive elements lie between À80 and À50 upstream of the promoter. Shortening the promoter fragment to À50/ þ 12 caused partial loss of an active NF-kB binding site (À52 to À44) and the Lf-induced transactivation was almost completely inhibited. Using a minimal promoter (À80/ þ 12) construct, treatment of cells with the proteasome inhibitor MG132, which blocks IkBa degradation and thereby inhibits NF-kB activation, greatly decreased the relative transactivation of p53 (Figure 2b ). The magnitude of the induction caused by recombinant TNF-a treatment was also diminished by MG132. As shown in Figure 2c , treatment of SN50 peptide, which specifically inhibits NF-kB nuclear translocation (Lin et al., 1995) blocked the Lf-induced p53 transactivation. These observations indicate that the NF-kB binding site is required for Lf to activate the p53 promoter. To exclude the possibility that the expression of nonrelevant protein may induce as Lf does in p53 transactivation, we examined the effect of GFP expression on the p53 activation. GFP expression did not affect the p53 promoter-driven CAT activity, indicating that the p53 activation is indeed due to the expression of Lf (Figure 2c ). In a previous report, Lf was shown to activate the major transcription factor AP-1 downstream of the stress-activated protein kinase signaling cascade (Oh et al., 2001) . We expected that Lf might participate in other signal transduction pathways such as the NF-kB activation pathway, since the proposed AP-1 activation pathway involving MAP kinases could be involved in regulating NF-kB activity (Schulze-Osthoff et al., 1997). To determine whether Lf can activate the NF-kB pathway, we employed the NF-kB-driven reporter constructs p2NFBCO and pJ16. Plasmid p2NFBCO contains four copies of the NF-kB site from the b-interferon gene promoter in front of a rabbit b-globin promoter, while plasmid pJ16 contains two copies of the murine immunoglobulin kappa light-chain enhancer NF-kB site linked to a minimal c-fos promoter. Plasmid pLf was cotransfected into cells with the NF-kB-driven reporter plasmids. p2NFBCO and pJ16 caused, respectively, 20-and 18-fold greater transactivation in cells transfected with pLf than in cells transfected with the empty vector as control (Figure 3a) . In contrast, cotransfection with pLf and pOBCO, which lacks the four copies of the NF-kB site in p2NFBCO, had no effect on CAT activity. Transient transfection with pJ32, a similar reporter plasmid to pJ16, except that it has only two nucleotide mutations on the NF-kB site, also demonstrated that the transactivation seen in pLf-transfected cells was NF-kB dependent (Figure 3b ). To determine whether ectopic expression of Lf can replace the expression of p50 and RelA, a major heterodimeric form of NF-kB, we cotransfected with pLf or p50/RelA plus either pJ16 or pJ32. The magnitude of the induction of expression was comparable to that generated by treatment of the cells with recombinant TNF-a, which served as a positive control for NF-kB activity. The transcriptional activity of pJ16 was also induced 20-fold against control by Lf and p50/RelA (Figure 3b ). In the case of pJ32 expression, both Lf and p50/RelA very weakly enhanced the transactivation activity. These results provide clear evidence that NF-kB is an essential mediator of Lf-induced transactivation.
Lf stimulates the activity of IKKb and NF-kB binding
To investigate whether Lf affects NF-kB binding to DNA, we performed gel retardation assays using nuclear extracts from B-hLf2, a Balb/c cell line overexpressing human Lf, with Balb/c-pCI-neo serving as a negative control. Overexpressed Lf greatly stimulated NF-kB DNA binding (Figure 4a ). To confirm specificity, we used a 50-fold molar excess of unlabeled NF-kB or Sp-1 oligonucleotides as a cold competitor. Also, the supershift assay showed that the enhanced formation of nuclear protein-NF-kB oligonucleotide complex by Lf indeed contained NF-kB comprised of p50 and p65 heterodimeric complex (Figure 4b ). This result suggests that the increase of NF-kB binding might result from phosphorylation of IkBa by IKK and its consequent degradation. Therefore, we examined the effect of Lf on IKK activity. As shown in Figure 4c , cotransfection with pLf and IKKb expression vectors revealed that IKKb was more markedly activated in the presence than in the absence of Lf. The relatively higher IKKb activity increased the phosphorylation of IkBa, resulting in its degradation. Therefore, a relatively low IkBa level was found in cells overexpressing Lf (Figure 4d ). We also showed by immunofluorescence that Lf induced translocation of NF-kB from the cytoplasm to the nucleus (Figure 5a ). Cotransfection of the plasmids expressing NF-kB subunit p65 and Lf into HeLa cells caused the were prepared from HeLa cells, which were transfected with each 5 mg of pLf ( þ ) or empty vector (À) plus p65 expression vector, pRSV-p65. TNF-a (50 ng/ml) was added in HeLa cells transfected with pRSV-p65 alone, and followed by incubation for 2 h.
Immunoblot analysis was performed with anti-p65 antibody. The membrane was stripped and reprobed with anti-actin antibody, which was used as a loading control Figure 4 Lf enhances activity of IKKb and NF-kB. (a) Nuclear extracts from Balb/c-pCI-neo (À) or Balb/c-Lf ( þ ) cells were incubated with 32 P-labeled NF-kB oligonucleotides. The DNAprotein complex was separated on 5% nondenaturing gel, dried, and analysed by autoradiography. A 50-fold molar excess of unlabeled NF-kB oligonucleotide (NF-kB oligo) or unlabeled Sp-1 oligonucleotide (Sp-1 oligo) was added for specific competition. TNF-a (30 ng/ml), an NF-kB activator, was treated for 30 min. The specific (NF-kB) or nonspecific complex (NS) is indicated, respectively. (b) Supershift assay was performed as described in 'Materials and methods'. Nuclear extracts from Balb/c-pCI-neo (À) or Balb/c-Lf ( þ ) cells were incubated with 32 P-labeled NF-kB oligonucleotides. Each 1 mg of p50 (a-p50) or p65 (a-p65) antibody was added and then incubated for 30 min. A 50-fold molar excess of unlabeled NF-kB oligonucleotide (NF-kB oligo) was added for specific competition. The specific (NF-kB) or supershifted complex (s.s.) is indicated, respectively. (c) The 293 cells were transfected with each 10 mg of Flag-IKKb and pLf ( þ ) or empty vector (À). In vitro kinase assay for IKKb was performed as described under 'Experimental procedures.' Each cellular lysate was subjected to immunoblotting (IB) using anti-FLAG antibody. The fold increase in activity relative to that of control is represented. The phosphorylated IkBa are indicated. (d) The 293 cells were transfected with each 10 mg of pLf ( þ ) or empty vector (À). At 40 h after transfection, Immunoblot analysis was performed using anti-IkBa antibody. The membrane was stripped and reprobed with anti-actin antibody, which was used as a loading control Lf-induced p53 activation via NF-kB involves the MEKK1 and NIK signaling pathways To elucidate the mechanism by which Lf expression causes p53 activation, we determined whether Lf triggers known NF-kB signaling pathways. TNF treatment activates both NF-kB and AP-1 (Song et al., 1997) . MAP kinases, including p38MAPK and JNK, might be involved in regulating NF-kB (Schulze-Osthoff et al., 1997). Therefore, we investigated the involvement of three distinct groups of downstream MAPKs: extracellular signal-regulated kinase (ERK), p38 MAPK, and JNK. For this purpose, we employed the kinase inhibitors PD98059 and SB203580, which are specific inhibitors of Raf-1 (upstream of ERK) and p38 MAPK, respectively. Treatment with PD98059 and SB203580 immediately after cotransfection with pLf and pJ16 had no significant effect on the Lf-mediated transactivation of pJ16 (Figure 6a ). Also, overexpression of a dominantnegative mutant of JNK1 did not block this transactivation (Figure 6b ). These results suggest that Lf-induced NF-kB activation does not involve downstream effectors, MAPKs, but might result from kinases upstream from IKK, including mitogen-activated protein kinase kinase kinases, MEKK1 and/or NIK.
A dominant-negative form of either MEKK1 or NIK blocks Lf-induced activation of both IKK and NF-kB
We then determined whether an upstream kinase of IKK, NIK or MEKK1, contributed to the Lf-induced activation of NF-kB in 293 cells. Overexpression of dominant-negative mutant of MEKK1, MEKK1D (K432M) or dominant-negative mutant of NIK, NIK (624-947) weakly inhibited Lf-mediated IKKb activity (Figure 7a ). However, a kinase-inactive NIK mutant, At 40 h post-transfection, nuclear extracts were prepared and followed by incubation with labeled NF-kB oligonucleotides. The DNAprotein complex was separated on 5% nondenaturing gel, dried, and analysed by autoradiography. The specific (NF-kB) complex is indicated NIK (KK429-430AA), almost abolished Lf-induced IKKb activity. Since the expression of Lf increases NF-kB binding to DNA (Figure 4) , we also examined whether blocking the IKK signaling cascade by kinaseinactive forms of NIK or MEKK1 could affect this binding. As expected, expression of MEKK1D (K432M), NIK (624-947), or NIK (KK429-430AA) markedly reduced NF-kB binding (Figure 7b ). Furthermore, Lf-mediated transactivation of the J16 gene was inhibited when pLf was coexpressed with MEKK1D (K432M), or NIK (624-947) and NIK (KK429-430AA) (Figure 8a ). Consistent with previous report , we found that overexpression of the kinaseinactive NIK (KK429-430AA) lacking two lysine residues in its catalytic domain always resulted in greater reduction of the Lf-induced activation of NFkB than overexpression of the kinase-inactive NIK (624-947) containing a TRAF2-interacting C-terminal domain. Similar results were also obtained using Balb/c cells (data not shown). These data demonstrate that upstream kinases of IKK, MEKK1 and NIK, acted on critical components of the signaling pathway involved in Lf-mediated activation of both IKK and NF-kB. In addition, both dominant-negative mutants of IKK, IKKa (K44A) and IKKb (K44A), inhibited Lf-mediated transcription of the J16 gene (Figure 8a ). Diminished NF-kB activation by Lf was also shown in IKKa-or IKKb-deficient mouse embryonic fibroblasts (MEF) (Figure 8b ). Thus, these data are consistent with both IKKa and IKKb having essential roles in the NF-kB signaling pathway and the induction of Lf-mediated p53 activation.
Discussion
In this study, we have found that overexpressed Lf activates p53 transcription in trans. Although it is not clear whether Lf influences the stability of p53 mRNA, p53 protein was also maintained at higher levels in Lfoverexpressing HeLa-Lf cells than control HeLa cells. Moreover, treatment of HeLa-Lf cells with the p53 inhibitor pifithrin-a reduced the induction of transcription from mdm2 and p21 waf1/cip1 promoters. It appears that transcriptional activation of p53 as well as the stability of the protein is responsible for p53 activation in response to Lf. In HeLa-Lf cells, we identified a mechanism that appears to mediate Lf-induced p53 activation. This includes a pathway activating the IKK that phosphorylates IkB, thereby leading to the activation of NF-kB. The activated NF-kB then induces p53 transcription and the p53 in turn transactivates transcription of the inducible genes mdm2 and p21 waf1/cip1 . As a cellular regulator in transcription and growth control, p53 plays an essential role in sensing various stress signals and serves as a focal point of signal integration to determine whether cells will undergo apoptosis or growth arrest (Levine, 1997) . It is known to be activated in response to numerous stress signals such as UV, g-irradiation, hypoxia, and anticancer agents (Kastan et al., 1992) . We have shown that overexpression of Lf transactivates transcription of p53 itself and other p53-responsive genes, indicating that a high level of Lf might be a stress mediator. Several transcription factors including NF-kB, AP-1, c-Myc and HoxA5 appear to be involved in activating the human p53 promoter (Kirch et al., 1999; Raman et al., 2000) . Among these transcription factors, NF-kB is known to activate p53 transcription in response to DNA damage (Hellin et al., 1998) . We showed by nested deletion analysis that the Lf-induced transactivation of p53 requires the presence of an active NF-kB binding site located between À52 and À44 upstream of the promoter. Partial deletion of the NF-kB site led to complete abrogation of reporter gene activation by Lf. In addition, a minimal p53 promoter did not affect the Lf-induced transactivation when cells were treated with the proteasome inhibitor MG132, which blocked IkBa degradation, thereby inhibiting NF-kB activation. Normally, the degradation of IkBa allows the nuclear translocation and DNA binding of NF-kB to regulate the transcription of many genes encoding cytokines, growth factors, and stress-response proteins. Indeed, we have observed that overexpression of Lf strongly induces the translocation of NF-kB from the cytoplasm to nucleus. These data provide direct evidence that functional inhibition of NF-kB alters Lf-induced p53 promoter activation and support the view that Lfinduced p53 activation requires the activation of NF-kB through IkBa degradation. We have investigated the pathway by which Lf activates NF-kB. Previously, we reported that constitutively overexpressed Lf induces the MKK4-SAPK signaling pathway, leading to the activation of AP-1 and expression of chemoattractants such as MCP-1 that cause leukocyte recruitment. It has been suggested that MAPKs including p38MAPK and JNK are involved in regulating NF-kB activity (Schulze-Osthoff et al., 1997) . Therefore, we investigated the involvement of downstream MAPKs, including ERK, p38 and JNK. Our data demonstrated that the downstream MAPKs did not directly affect Lf-mediated NF-kB-dependent transcription. Therefore, we turned our attention to upstream signaling components such as the IKK complex, NIK or MEKK1 (Lee et al., 1998; Ling et al., 1998) . Using dominant negative mutants, we found that upstream components of NF-kB, IKKb, NIK or MEKK1 participated in NF-kB activation on Lf signaling. Once Lf was overexpressed in cells, one of the TRAFs that have affinity for various downstream signaling components is probably recruited to relay signals to NIK, MEKK1, or the IKK complex downstream (manuscript in preparation). However, several potential upstream IKK kinases, including MEKK1, MEKK2, MEKK3, NIK, TBK1 and TAK1 (Zhao and Lee, 1999; Li and Verma, 2002) , have been suggested as Lf-specific effectors.
The biological role of the p53 activation by Lf and the mechanism by which Lf activates the IKK/NF-kB pathway have not yet been fully elucidated, but some experiments support the role of Lf leading to the activation of genes. Our hypothesis of the control mechanism of the overexpressed Lf through a signal transduction agrees with results of internalization studies, which suggested that Lf could be taken up by many mammalian cells containing Lf receptors (Garre et al., 1992; Mikogami et al., 1994; Suzuki and Lonnerdal, 2002) . We and others observed that specific mammalian cells such as monocytes and intestinal cells, which had Lf receptors on their cell surface, were responsive to Lf added to culture medium. Thus, Lf may be internalized by target cells, in which target gene activation may occur. However, the majority of the Lf is degraded after the transportation, and a minor portion of Lf acts functionally (Suzuki and Lonnerdal, 2002) . We also observed that Western analysis detected the faint bands corresponding to both intact and degraded Lf in Balb cells transfected with either pLf or pS À Lf (data not shown). Furthermore, recent data obtained in our laboratory demonstrated that Lf interacted specifically with certain upstream target molecules associated with the signaling, indicating the involvement of Lf receptors or their equivalents in further upstream signaling immediately following the binding event (manuscript in preparation). These observations reveal the nature of Lf usage by other target cells and suggest, in part, ways of intracellular Lf working in this phenomenon. However, various modes of action of Lf remain to be elucidated. Further work will be necessary to characterize the molecular mechanism by which Lf activates the signaling pathway in greater details.
Materials and methods
Cells and reagents
Wild-type MEF cells, IKKa-, and IKKb-deficient MEF cells (kindly provided by Dr I Verma), 293 cells, Balb/c-3T3 cells, and HeLa cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. Balb/c-3T3 cells or HeLa cells stably transfected with pLf, Balb/c-Lf, or HeLa-Lf were described previously (Oh et al., 2001) . TNFa, PD98059, SB203580, MG132, pifithrin-a, mitomycin C, and monoclonal anti-FLAG M2 antibody were purchased from Sigma. NF-kB SN50, cell-permeable inhibitor peptide was from Calbiochem. Protein G-plus agarose and anti-actin, antiIkBa, anti-p65, and anti-p53 antibodies were from Santa Cruz Biotechnology.
Plasmids
Lf expression plasmids, pLf and pS -Lf, which lacks its 5 0 signal sequence for secretion, were kindly provided by Dr P Furmansky (He and Furmanski, 1995) . Briefly, pLf contains the full-length Lf cDNA inserted into ApaI and BamHI sites of pcDNA3 (Invitrogen). The GFP expression vector pEGFP-C1 was from Clontech. Dominant-negative mutants of SEK1 and JNK1 were described previously (Oh et al., 2001) . NF-kBdriven CAT reporter genes, pJ16 and p2NFBCO, were gifts of Dr T Gilmore. Expression vectors for wild-type IKKs, pRKFlag-IKKa, and pRK-Flag-IKKb, expression vectors for dominant-negative IKKs, pRK-Flag-IKKa (K44A), and pRK-Flag-IKKb (K44A), expression vectors for dominantnegative NIK, pRK-Flag-NIK (624-947), and pRK-Flag-NIK (KK429-430AA) were kindly provided by Dr D Goeddel, TularikInc.ExpressionvectorsencodingMEKK1andMEKK1D (K432M) were gifts from Dr T Maniatis. Bacterial expression vector for GST-IkBa (1-55) was provided by Dr J Hiscott. Construction of human p53 gene promoter-driven reporter genes, p53CAT(À325/ þ 12), p53CAT(À80/ þ 12), and p53CAT(À50/ þ 12), was performed using PCR technique. Expression vector for human wild-type Mdm2 (pCMV-NeoBam-mdm2) was provided by Dr Y Haupt. The p53-dependent reporter genes Mdm2-NA-LUC and WWP-LUC were gifts from Dr M Oren and Dr B Vogelstein, respectively.
Small interfering RNAs
The duplex siRNA (5 0 -CCCGAGGCCACAAAAUGCU-3 0 ) with two thymidine residues (dTdT) at the 3 0 -end of the sequence was designed for Lf gene (Qiagen). The duplex siRNA (5 0 -GCAAGCUGACCCUGAAGUUCAU-3 0 ) for GFP gene (GFP-22 siRNA) was obtained from licensed siRNA library (Qiagen) and used as a control. HeLa-pCIneo or HeLa-Lf cells were transfected with each siRNA (5 mg) using RNAiFect reagents (Qiagen). At 72 h after transfection, cells were harvested and analysed for reverse transcription-PCR (RT-PCR).
Transfections and reporter gene assays
For reporter gene assays, transient transfections were carried out using calcium phosphate precipitation method or lipofectamine 2000 (Invitrogen) with equal amount of pLf or empty vector together with NF-kB-responsive reporter genes pJ16 or p2NFBCO, and p53-responsive reporter gene Mdm2-NA-LUC or WWP-LUC, and various kinds of each expression construct. Cotransfection with the pRSV-b-galactosidase plasmid (0.5 mg per transfection) and b-galactosidase activity were normalized for transfection efficiency. At 40 h after transfection, cells were harvested and followed by CAT assay (Oh et al., 2001) or luciferase assay.
In vitro kinase assay
Kinase assay was performed as described . Briefly, 293 cells were transfected with a total of 10 mg of pLf or empty vector, pRK-Flag-IKKb, and the indicated each expression vector. At 40 h post-transfection, cells were harvested, washed with PBS, and lysed. A total of 500 mg total cellular proteins were incubated with 1 mg anti-FLAG monoclonal antibody (Sigma) and protein G-plus agarose. The immunocomplexes were incubated for 30 min at 301C in kinase buffer containing GST-IkBa and analysed by SDS-polyacrylamide gel electrophoresis and autoradiography.
Immunoblotting and EMSA
Each immunoblot analysis was carried out as described (Oh et al., 2001) . Nuclear extracts were prepared from Balb/c-pCIneo cells, Balb/c-Lf cells, or 293 cells transiently transfected (Andrews and Faller, 1991) and EMSAs were performed as described previously (Weng et al., 1995) . To use as a probe, oligonucleotides (5 0 -AGTTGAGGGGACTTTCCCAGGC-3 0 ) with a consensus NF-kB site were end labeled with [g-32 P]ATP using T4 polynucleotide kinase (Promega). Supershift assay was carried out with antibodies against p65 and p50 proteins. Briefly, 5 mg of nuclear extracts was incubated for 30 min at room temperature in 20 ml of binding buffer (10 mM Tris-Cl (pH 7.5), 50 mM NaCl, 1 mM DTT, 1 mM EDTA, 5% glycerol) containing 1 mg poly-dI-dC and 0.5 ng [g-32 P]ATP-labeled NF-kB oligonucleotides. After 30 min incubation, 1 mg of each antibody was added and then additionally incubated for 30 min at room temperature. DNA-protein complex was resolved by electrophoresis in native 4% polyacrylamide gel. The gel was dried and exposed to X-ray film for analysis.
Reverse transcription-PCR
Total RNA was extracted from HeLa-pCI-neo cells or HeLaLf cells using the guanidinium thiocyanate-CsCl-mediated method (Oh et al., 2001) . Reverse transcription and PCR amplification were performed using SUPERSCRIPT II RNase H-reverse transcriptase (Invitrogen) and pfu DNA polymerase (Promega). PCR was performed for 25 cycles at 951C for 2 min, 951C for 20 s, 551C for 30 s, and 681C for 40 s. The PCR products were analysed on a 1.5% agarose gel and stained with ethidium bromide for visualization.
Immunofluorescence assay
HeLa cells on coverslips in six-well plates were transfected with each 0.5 mg of pLf or empty vector and pRSV-p65. At 40 h post-transfection, the cells were washed with PBS, fixed with 3% paraformaldehyde for 10 min, and then incubated with 0.5% Triton X-100 for 10 min at room temperature. After washing, cells were incubated with anti-p65 monoclonal antibody (1 : 100) in PBS containing 1% BSA for 60 min and followed by incubation with anti-mouse IgG FITC conjugate in PBS containing 1% BSA for 30 min. The coverslips was inverted on glass slides dropped with mounting medium. Images were analysed using Zeiss Axioskop 2 microscope configured for epifluorescence and equipped with a camera device.
